- Forums
- ASX - By Stock
- IXC
- Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021
Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-74
-
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.885M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 131690 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.7¢ | 7950 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 131690 | 0.060 |
1 | 11528 | 0.053 |
1 | 100000 | 0.052 |
2 | 410000 | 0.051 |
1 | 60001 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.077 | 7950 | 1 |
0.078 | 20000 | 1 |
0.081 | 888 | 1 |
0.083 | 4000 | 1 |
0.086 | 68122 | 1 |
Last trade - 10.04am 03/07/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online